Oxybutynin Dosing Recommendations
For adults, start with 5 mg two to three times daily (maximum 20 mg/day in divided doses), while frail elderly patients should begin at 2.5 mg two to three times daily; children ≥5 years should receive 5 mg twice daily (maximum 15 mg/day). 1
Adult Dosing
Standard adult dose: 5 mg tablet two to three times daily 1. The maximum recommended dose is 5 mg four times daily (20 mg total daily dose) 1.
- Extended-release formulations allow once-daily dosing at 5-30 mg/day, with most patients tolerating doses up to 30 mg 2, 3
- Dose titration can occur in weekly increments of 5-10 mg based on efficacy versus side effects 3
- Clinical improvement may be observed within 1 week of initiation 3
Elderly Patients
A lower starting dose of 2.5 mg two or three times daily is specifically recommended for the frail elderly 1. This reduction accounts for the prolonged elimination half-life in elderly patients (5 hours versus 2-3 hours in younger adults) 1.
The frail elderly require cautious dosing due to:
- Decreased hepatic and renal function
- Greater frequency of concomitant disease
- Increased risk of anticholinergic CNS effects (confusion, hallucinations, somnolence) 1
Important caveat: While studies show elderly patients (≥65 years) can tolerate standard doses with good efficacy 4, the FDA label prioritizes safety in frail elderly with the 2.5 mg starting dose 1.
Pediatric Dosing (≥5 Years)
Children over 5 years: 5 mg tablet twice daily 1. The maximum recommended dose is 5 mg three times daily (15 mg total daily dose) 1.
- Safety and efficacy established in children ≥5 years, particularly those with neurogenic bladder 1
- Children weighing <25 kg generally should not receive single doses >15 mg 1
- Oxybutynin is NOT recommended for children under 5 years due to insufficient clinical data 1
Hepatic or Renal Impairment
Use with caution in patients with hepatic or renal impairment 1. While the FDA label does not provide specific dose adjustments for hepatic/renal impairment with oral oxybutynin 1, general principles apply:
- Start at the lower end of the dosing range
- Monitor closely for anticholinergic side effects
- Consider the frail elderly dosing approach (2.5 mg two to three times daily) as a conservative starting point
Key Monitoring Points
Anticholinergic side effects are dose-related and include 1:
- Dry mouth (most common: 24.8% in younger adults, 36% in elderly) 4
- Constipation
- Blurred vision
- Urinary retention
- CNS effects (confusion, hallucinations, somnolence)
Monitor patients in the first few months after beginning treatment or dose increases for anticholinergic CNS effects; consider dose reduction or discontinuation if these occur 1.
Contraindications and Special Precautions
Absolute contraindications include narrow-angle glaucoma (unless approved by ophthalmologist) and severe gastric emptying disorders 5, 1.
Use extreme caution in patients with: